Pharmaceuticals Acquisitions in South Carolina

Novo Holdings A/S has agreed to acquire The Ritedose Corporation from AGIC Capital and Humanwell. Ritedose, a Columbia, South Carolina-based sterile pharmaceutical manufacturer specializing in blow-fill-seal (BFS) technology for ophthalmic, respiratory and vaccine products, employs more than 400 people and will remain led by CEO Jody Chastain; the transaction is expected to close in Q1 2022.

Enhanced Healthcare Partners (EHP), together with Bourne Partners Strategic Capital (BPSC), announced the acquisition of Pharmaceutical Associates, Inc. (PAI), a U.S. manufacturer of generic liquid and unit-dose pharmaceuticals. The investment will provide growth capital to expand PAI's manufacturing capacity, product lines and market footprint while leveraging BPSC's pharmaceutical network and EHP's healthcare investment experience.